Laparoscopic liver resection is associated with less significant muscle loss than the conventional open approach

World J Surg Oncol. 2022 Dec 4;20(1):385. doi: 10.1186/s12957-022-02854-1.

Abstract

Background: Laparoscopic liver resections (LLR) have been shown a treatment approach comparable to open liver resections (OLR) in hepatocellular carcinoma (HCC). However, the influence of procedural type on body composition has not been investigated. The aim of the current study was to compare the degree of skeletal muscle loss between LLR and OLR for HCC.

Methods: By using propensity score matching (PSM) analysis, 64 pairs of patients were enrolled. The change of psoas muscle index (PMI) after the operation was compared between the matched patients in the LLR and OLR. Risk factors for significant muscle loss (defined as change in PMI > mean change minus one standard deviation) were further investigated by multivariate analysis.

Results: Among patients enrolled, there was no significant difference in baseline characteristics between the two groups. The PMI was significantly decreased in the OLR group (P = 0.003). There were also more patients in the OLR group who developed significant muscle loss after the operations (P = 0.008). Multivariate analysis revealed OLR (P = 0.023), type 2 diabetes mellitus, indocyanine green retention rate at 15 min (ICG-15) > 10%, and cancer stage ≧ 3 were independent risk factors for significant muscle loss. In addition, significant muscle loss was associated with early HCC recurrence (P = 0.006). Metabolomic analysis demonstrated that the urea cycle may be decreased in patients with significant muscle loss.

Conclusion: LLR for HCC was associated with less significant muscle loss than OLR. Since significant muscle loss was a predictive factor for early tumor recurrence and associated with impaired liver metabolism, LLR may subsequently result in a more favorable outcome.

Keywords: Hepatectomy; Hepatocellular carcinoma; Laparoscopic; Liver resection; Muscle loss; Sarcopenia.

MeSH terms

  • Carcinoma, Hepatocellular* / surgery
  • Diabetes Mellitus, Type 2*
  • Humans
  • Laparoscopy* / adverse effects
  • Liver Neoplasms* / surgery
  • Muscle, Skeletal